Catalog exploration ranks

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Derivative structure exploration tiers · CNS

Rule-based Catalog Exploration Score from SMILES similarity, approved/clinical tags, family network size, and SAR metadata. It does not predict efficacy, safety, or development success.

전체 도메인 신경 하이라이트 Chemometric Deep Analysis →

Core 후보 1파생 후보 61 패밀리

Core 구조 파생 구조 구조 탐색

MedMedium exploration priority1

Upper-mid Exploration Score percentile (X-A bin)

High exploration priority	2D	Structure	Class	Exploration Score	Factors
Med		Edaravone (Radicava) ALS neuroprotectant series · Drug	ALS	70	Drug · SMILES 확보 · 승인·상용

MedEdaravone (Radicava)

ALS neuroprotectant series · Drug · ALS

Drug · SMILES 확보 · 승인·상용

MedMedium exploration priority2

Mid-pool Exploration Score (X-B bin)

High exploration priority	2D	Structure	Class	Exploration Score	Factors
Med		Riluzole (Rilutek) ALS neuroprotectant series · Drug	ALS	70	Drug · SMILES 확보 · 승인·상용
Med		Sodium phenylbutyrate (Relyvrio component) ALS neuroprotectant series · Drug	ALS	70	Drug · SMILES 확보 · 승인·상용

MedRiluzole (Rilutek)

ALS neuroprotectant series · Drug · ALS

Drug · SMILES 확보 · 승인·상용

MedSodium phenylbutyrate (Relyvrio component)

ALS neuroprotectant series · Drug · ALS

Drug · SMILES 확보 · 승인·상용

LowLow exploration priority3

Lower Exploration Score — still listed for inspection (X-C bin)

High exploration priority	Structure	Class	Exploration Score	Factors
Low	Taurursodiol (Relyvrio component) ALS neuroprotectant series · Drug	ALS	70	Drug · SMILES 확보 · 승인·상용
Low	Des-trifluoromethoxy riluzole analog ALS neuroprotectant series · Derivative	ALS	38	Derivative · SMILES 확보
Low	Edaravone methyl-walk analog ALS neuroprotectant series · Derivative	ALS	38	Derivative · SMILES 확보

LowTaurursodiol (Relyvrio component)

ALS neuroprotectant series · Drug · ALS

Drug · SMILES 확보 · 승인·상용

LowDes-trifluoromethoxy riluzole analog

ALS neuroprotectant series · Derivative · ALS

Derivative · SMILES 확보

LowEdaravone methyl-walk analog

ALS neuroprotectant series · Derivative · ALS

Derivative · SMILES 확보

Exploration score method

StructureMoa ranks are a rule-based Exploration Score. An LLM does not predict activity or efficacy. Role, SMILES, and relation signals inside each family are summed and cut into High / Medium / Low exploration priority.

Core tab

scaffold / payload / linker role weights
family center-compound bonus
SMILES source (db · known · pubchem · inherited)
relation-edge count and derived-child count

Derivative tab

drug / derivative / adc candidates
similarity to family center via Morgan fingerprint, radius 2, 2048 bits, Tanimoto
approved / clinical catalog-tag bonuses
ADC / payload tags

Explore tab

sparse SAR, cross-scaffold pairs, expansion leaves
weakly linked nodes and approved-tag neighborhood gaps
relation graph + stored Morgan fingerprints
category filters

Exploration-priority bins

High (X-S): top ~12%
Medium (X-A/X-B): ~12–62%
Low (X-C): remainder (pools under 5 compounds stay Medium)

Internal exploration metric based on catalog and structural signals. Not a prediction of efficacy, safety, potency, or development success.

Full methodology

평가 시각: 2026. 9. 11. 오전 5:34:02 · 캐시 5분 · 전체 패밀리